OPTIMER PHARMACEUTICALS INC Operating Income
OPTIMER PHARMACEUTICALS INC reported Operating Income of -$27.12 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-06-30 was -$27.12M, a 8359.82% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-03-31 was -$31.49M.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-12-31 was -$30.32M, a 337.77% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-09-30 was -$26.27M.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for fiscal 2012 was -$90.84M, a 1710.97% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was $5.64M.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was -$48.87M.
- OPTIMER PHARMACEUTICALS INC operating income (loss) for fiscal 2009 was -$42.60M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2013-06-30 | -$27.12M 10-Q · filed 2013-08-07 | -$58.61M 10-Q · filed 2013-08-07 | -$88.93M derived: sum of 3 quarters · filed 2013-08-07 | -$115.20M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2013-03-31 | -$31.49M 10-Q · filed 2013-05-10 | -$61.81M derived: sum of 2 quarters · filed 2013-05-10 | -$88.08M derived: sum of 3 quarters · filed 2013-05-10 | -$87.75M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-12-31 | -$30.32M 10-K · filed 2013-03-18 | -$56.59M derived: sum of 2 quarters · filed 2013-03-18 | -$56.26M derived: sum of 3 quarters · filed 2013-08-07 | -$90.84M 10-K · filed 2013-03-18 | |
| 2012-09-30 | -$26.27M 10-K · filed 2013-03-18 | -$26.27M 10-Q · filed 2012-11-02 | -$25.94M derived: sum of 2 quarters · filed 2013-08-07 | -$60.52M 10-Q · filed 2012-11-02 | -$47.77M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | $328.33K 10-Q · filed 2013-08-07 | -$34.25M 10-Q · filed 2013-08-07 | -$21.49M derived: sum of 3 quarters · filed 2013-08-07 | -$48.41M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-03-31 | -$34.57M 10-Q · filed 2013-05-10 | -$21.82M derived: sum of 2 quarters · filed 2013-05-10 | -$48.74M derived: sum of 3 quarters · filed 2013-05-10 | -$73.75M derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $12.75M 10-K · filed 2013-03-18 | -$14.16M derived: sum of 2 quarters · filed 2013-03-18 | -$39.18M derived: sum of 3 quarters · filed 2013-03-18 | $5.64M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$26.91M 10-K · filed 2013-03-18 | -$26.91M 10-Q · filed 2011-11-03 | -$51.93M derived: sum of 2 quarters · filed 2013-03-18 | -$7.11M 10-Q · filed 2012-11-02 | -$19.60M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$25.02M 10-K · filed 2013-03-18 | -$25.02M 10-Q · filed 2011-08-04 | $19.80M 10-Q · filed 2012-08-03 | $7.31M derived: sum of 3 quarters · filed 2013-03-18 | -$4.94M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $44.82M 10-K · filed 2013-03-18 | $44.82M 10-Q · filed 2012-05-10 | $32.33M derived: sum of 2 quarters · filed 2013-03-18 | $20.08M derived: sum of 3 quarters · filed 2013-03-18 | $9.67M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | -$12.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$24.74M derived: sum of 2 quarters · filed 2013-03-18 | -$35.15M derived: sum of 3 quarters · filed 2013-03-18 | -$48.87M 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$12.25M 10-Q · filed 2011-11-03 | -$22.66M derived: sum of 2 quarters · filed 2011-11-03 | -$36.38M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$10.40M 10-Q · filed 2011-08-04 | -$24.13M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$42.60M 10-K · filed 2012-03-08 |